Banque Pictet & Cie’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
– Sell
-14,460
Closed -$5.09M – 383
2023
Q4
$5.09M Buy
14,460
+994
+7% +$352K 0.04% 153
2023
Q3
$5.05M Buy
+13,466
New +$5.21M 0.06% 141

Other funds holding WST

Banque Pictet & Cie's WST Position: Q1 2024 in Review

Banque Pictet & Cie sold out of West Pharmaceutical (WST) in Q1 2024, closing a stake of 14,460 shares — an estimated $5.09M sold.

Banque Pictet & Cie first reported a position in WST in Q3 2023 and held it in 2 quarters. The position peaked at $5.09M in Q4 2023. 778 funds tracked by Wall St. Rank hold WST as of Q1 2024.

  • Banque Pictet & Cie reported no remaining West Pharmaceutical position as of Q1 2024 after selling out during the quarter.
  • Banque Pictet & Cie sold 14,460 West Pharmaceutical shares in Q1 2024, an estimated $5.09M.
  • Banque Pictet & Cie first reported a position in West Pharmaceutical in Q3 2023 and held it in 2 quarters.
  • Banque Pictet & Cie's West Pharmaceutical position peaked at $5.09M in Q4 2023.
  • 778 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2024.

Based on Banque Pictet & Cie's 13F filing for Q1 2024, filed 6 May 2024.